Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.55 USD | -0.22% | +2.02% | +14.56% |
06-25 | Oppenheimer Initiates Keros Therapeutics at Outperform With $102 Price Target | MT |
06-18 | Keros Therapeutics Names Chief Executive Officer Jasbir Seehra as Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.56% | 1.65B | |
+16.49% | 122B | |
+21.73% | 116B | |
+22.18% | 27.03B | |
-21.81% | 20.36B | |
-16.89% | 16.43B | |
-18.81% | 15.91B | |
-44.74% | 15.6B | |
+62.72% | 14.94B | |
+3.09% | 13.59B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics Names Chief Executive Officer Jasbir Seehra as Board Chair